Tissue DonorsBlood DonorsLiving DonorsTransplantation, HomologousBone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation ConditioningHistocompatibilityGraft SurvivalGraft vs Leukemia EffectGraft vs Tumor EffectAcute DiseaseLymphocyte TransfusionImmunosuppressive AgentsGraft vs Host ReactionLymphocyte DepletionLeukocyte TransfusionTissue and Organ ProcurementT-LymphocytesHLA AntigensWhole-Body IrradiationAnemia, AplasticTransplantation ChimeraLiver TransplantationTransplantation ImmunologyGraft RejectionMice, Inbred C57BLRadiation ChimeraTreatment OutcomeChronic DiseasePeripheral Blood Stem Cell TransplantationIsoantigensKidney TransplantationAntilymphocyte SerumRecurrenceRetrospective StudiesPhotopheresisBusulfanMice, Inbred BALB CCord Blood Stem Cell TransplantationMinor Histocompatibility AntigensTime FactorsSurvival AnalysisTissue and Organ HarvestingSpleenHistocompatibility TestingCD4-Positive T-LymphocytesImmunosuppressionTransplantation, IsogeneicVidarabineStem Cell TransplantationBrain DeathConsensus Development Conferences, NIH as TopicSiblingsNuclear FamilyCD8-Positive T-LymphocytesGraft vs Host DiseaseChimeraCadaverLymphocyte ActivationMice, Inbred DBAChimerismLeukemia, Myelogenous, Chronic, BCR-ABL PositiveInsemination, Artificial, HeterologousMethotrexateSurvival RateTacrolimusTransplantsHematologic DiseasesLymphocyte Culture Test, MixedT-Lymphocytes, RegulatoryMyeloablative AgonistsHost vs Graft ReactionBlood TransfusionUnrelated DonorsDisease-Free SurvivalAntibodies, MonoclonalT-Lymphocyte SubsetsInfectionOocyte DonationLymphocytesFlow CytometryMice, Inbred C3HImmune ToleranceSkinInterferon-gammaGranulocyte Colony-Stimulating FactorT-Lymphocytes, CytotoxicRisk FactorsCells, CulturedSkin TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic SyndromesRemission InductionTransplantation ToleranceIsoantibodiesLeukemia, Myeloid, AcuteMice, Inbred StrainsOrgan PreservationCyclophosphamide